|By Marketwired .||
|May 12, 2014 04:05 PM EDT||
O'FALLON, MO -- (Marketwired) -- 05/12/14 -- Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced the completion of a cooperative development agreement with Cleveland Clinic to develop next generation intraoperative devices. These devices are expected to lead to improved visualization of surgical sites leading to more precise tissue targeting and improved surgical outcomes. The agreement calls for Synergetics to provide research and development resources for the collaborative development of specific devices designed for the purpose of significantly advancing the nature of vitreoretinal surgery as it is performed today.
"We are pleased to enter into this collaborative agreement with Cleveland Clinic," stated Dave Hable, President and Chief Executive Officer of Synergetics USA, Inc. "We continue to focus on our objective of advancing ophthalmic surgery options and improving performance through the development of next generation intraoperative devices."
About Synergetics USA, Inc.
Through continuous improvement and development of our people, our mission is to design, manufacture and market innovative surgical devices, capital equipment, accessories and disposables of the highest quality in order to assist and enable surgeons who perform surgery around the world to provide a better quality of life for their patients.
Synergetics USA, Inc. (the "Company") is a leading supplier of precision surgical devices. The Company's primary focus is on the disciplines of ophthalmology and neurosurgery. The Company's distribution channels include a combination of direct and independent vitreoretinal sales organizations, both domestically and internationally, and important strategic alliances with market leaders. The Company's product lines focus upon precision engineered, disposable and reusable devices, surgical equipment, procedural kits and the delivery of various energy modalities for the performance of surgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency energy for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company's website address is http://www.synergeticsusa.com.
SYNERGETICS USA, INC.
3845 Corporate Centre Drive
O'Fallon, Missouri 63368
Attn: Pamela G. Boone, Chief Financial Officer